Skip to content

MBX Biosciences, Inc.

MBX· Nasdaqxbrl foundCIK 1776111

Pharmaceutical preparations552 peers

Close
Oct 23, 2026 · -7.68%
Market cap
$2.41B
49.64M shares
Filings
238
—
—
—
-$62.42M
Q3 2026N/M FY25 yoy
-$66.34M
Q3 2026N/M FY25 yoy
-$80.24M
Q3 2026derivedN/M FY25 yoy
-$1.29
Q3 2026N/M FY25 yoy
$161.69M
Q3 2026+52.6% FY25 yoy
$2.41B
—
—
5.1×
-3.40%
—

FY2025 figures · derived

Price

$48.50+227.92%+$33.71past year
Oct 23, 2026 · Official close
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Research And Development

$79.16MFY 2025
$79.16M0FY 2023FY 2024FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$79,159,000reported
FY 20242024-12-31$57,415,000reported
FY 20232023-12-31$28,534,000reported

Pharmaceutical preparations

MBX Biosciences, Inc. is the 80th largest of the 553 covered companies the SEC files under this code, by market cap. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

MBX Biosciences, Inc. · CIK 1776111 · Engraved from SEC EDGAR